Pramodini Medicare Ltd vs Qms Medical Allied Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Pramodini Medicare Ltd is ₹ 108.65 as of 23 Oct 15:30 . The P/E Ratio of Pramodini Medicare Ltd changed from 0 on March 2024 to 0 on March 2023 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of QMS Medical Allied Services Ltd changed from 23.2 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years The Market Cap of Pramodini Medicare Ltd changed from ₹ 0 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of QMS Medical Allied Services Ltd changed from ₹ 208.93 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 years The revenue of Pramodini Medicare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of QMS Medical Allied Services Ltd for the Jun '26 is ₹ 57.28 crore as compare to the Mar '26 revenue of ₹ 44.65 crore. This represent the growth of 28.29% The ebitda of Pramodini Medicare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of QMS Medical Allied Services Ltd for the Jun '26 is ₹ 8.73 crore as compare to the Mar '26 ebitda of ₹ 6.13 crore. This represent the growth of 42.41% The net profit of Pramodini Medicare Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of QMS Medical Allied Services Ltd changed from ₹ 2.4 crore to ₹ 3.96 crore over 9 quarters. This represents a CAGR of 24.93% The Dividend Payout of Pramodini Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of QMS Medical Allied Services Ltd changed from 9.92 % on March 2024 to 144.54 % on March 2026 . This represents a CAGR of 144.24% over 3 years .

About Pramodini Medicare Ltd

Pramodini Medicare Limited was originally incorporated on September 12, 2000 as 'Pramodini Medicare Private Limited' with the Registrar of Companies, Andhra Pradesh.
Thereafter, the status of the Company changed to public limited Company and the name was changed to 'Pramodini Medicare Limited' vide fresh certificate of incorporation dated November 12, 2025. Company was originally incorporated in the year 2000 with the objective to provide diagnostic services.
The Company provide a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. Diagnostic services include a comprehensive range of offerings: (i) 'Radiology' which covers Magnetic Resonance Imaging (MRI), Computed Tomography (CT scan), X- ray, Ultrasound with colour doppler, Mammography, DEXA Scan and Intervention Radiology, (ii) 'Clinical Laboratory' which includes Haematology, Micro-Biology, Immunology, Pathology & Bio-Chemistry and (iii) 'Nuclear Medicine' which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography) and Nuclear therapy.

About QMS Medical Allied Services Ltd

QMS Medical Allied Services Limited was incorporated as 'QMS Medical Allied Services Private Limited' on September 14, 2017.
The status of the Company was changed to Public Limited and name of the Company changed to QMS Medical Allied Services Limited on October 22, 2020.
The Company is engaged in marketing, trading and distribution of a wide range of Medical Products, Medical and Surgical Instruments, Medical Equipments & Accessories and Medical Devices. Presently, the Company manage a wide range portfolio of products sold under brand 'Qdevices' and also distribution for other brands such as 3M, Heine, Rossmax etc.
Further, it organizes and provides medical education to members belonging to medical fraternity like, physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other healthcare professionals by partnering with renowned medical education institutions such as EACME.

FAQs for the comparison of null and QMS Medical Allied Services Ltd

Which company has a larger market capitalization, Pramodini Medicare Ltd or QMS Medical Allied Services Ltd?

Market cap of Pramodini Medicare Ltd is 239 Cr while Market cap of QMS Medical Allied Services Ltd is 333 Cr

What are the key factors driving the stock performance of Pramodini Medicare Ltd and QMS Medical Allied Services Ltd?

The stock performance of Pramodini Medicare Ltd and QMS Medical Allied Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Pramodini Medicare Ltd and QMS Medical Allied Services Ltd?

As of October 25, 2026, the Pramodini Medicare Ltd stock price is INR ₹108.65. On the other hand, QMS Medical Allied Services Ltd stock price is INR ₹172.21.

How do dividend payouts of Pramodini Medicare Ltd and QMS Medical Allied Services Ltd compare?

To compare the dividend payouts of Pramodini Medicare Ltd and QMS Medical Allied Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.